Plaque-fighting nanoparticles could help prevent heart attacks and strokes

Scientists have created a new type of nanoparticle capable of not only imaging harmful plague inside arteries using MRI but simultaneously treating it as well. The findings were announced at the National Meeting and Exposition of the American Chemical Society.

The nanoparticle is designed to mimic the functions of the body’s own high-density lipoprotein (HDL), also known as “good” HDL cholesterol, which extracts low-density lipoprotein, or "bad" cholesterol, from arterial plaques. A hydrophobic core of iron oxide makes the nanoparticle light up on MRI scans, revealing the exact location of plaque buildup.

Researchers are currently studying how well the particles locate and treat plaques in animals, with clinical trials expected to begin within two years.

John Hocter,

Digital Editor

With nearly a decade of experience in print and digital publishing, John serves as Content Marketing Manager. His professional skill set includes feature writing, content marketing and social media strategy. A graduate of The Ohio State University, John enjoys spending time with his wife and daughter, along with a number of surprisingly mischievous indoor cacti.

Around the web

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services. 

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.

Trimed Popup
Trimed Popup